| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Interest income: |
| Interest income on loans | 20.8 | 14.4 | 11.9 | 11.3 | 11.0 | 11.6 | 12.3 | 11.9 |
| Interest income on investments | 1.5 | 1.5 | 1.4 | 1.4 | 1.2 | 1.2 | 1.1 | 1.0 |
| Interest income on repurchase agreements | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| | 22.8 | 16.3 | 13.6 | 12.8 | 12.3 | 12.8 | 13.4 | 12.9 |
| Interest expense: |
| Interest on deposits | 3.9 | 1.8 | 0.8 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 |
| | 5.5 | 2.2 | 1.0 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 |
| Net interest income | 17.4 | 14.1 | 12.6 | 12.0 | 11.5 | 12.0 | 12.5 | 11.9 |
| Provision for loan losses | 0.5 | | | | | -0.2 | | 0.2 |
| Net interest income after provision for loan losses | 16.8 | 14.1 | 12.6 | 12.0 | 11.5 | 12.2 | 12.5 | 11.7 |
| Other non-interest income | 1.6 | 2.4 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.6 |
| Total non-interest income | 1.6 | 2.4 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.6 |
| Non-interest expenses | 12.1 | 12.3 | 8.9 | 8.5 | 8.3 | 7.9 | 7.9 | 7.9 |
| Pre-tax income before non-recurring items | 6.1 | 5.4 | 5.3 | 5.1 | 4.6 | 5.9 | 6.4 | 5.4 |
| Non-recurring items | | 1.2 | | | | | | |
| Asset impairment | | | | 0.2 | | | | |
| Pre-tax income | 6.1 | 4.2 | 5.3 | 4.9 | 4.6 | 5.9 | 6.4 | 5.4 |
| Income taxes | 1.0 | 0.7 | 1.0 | 0.8 | 0.8 | 1.0 | 1.2 | 1.0 |
| Tax rate | 16.2% | 15.7% | 19.2% | 16.1% | 16.8% | 17.5% | 18.4% | 17.9% |
| Net income | 5.1 | 3.5 | 4.2 | 4.1 | 3.8 | 4.8 | 5.2 | 4.4 |
| Net margin | 27.7% | 21.2% | 30.0% | 30.5% | 29.8% | 35.2% | 36.4% | 33.3% |
| |
| Basic EPS | $0.63 | $0.58 | $0.73 | $0.70 | $0.65 | $0.78 | $0.85 | $0.70 |
| Diluted EPS | $0.63 | $0.58 | $0.73 | $0.70 | $0.65 | $0.78 | $0.85 | $0.70 |
| |
| Shares outstanding (basic) | 8.1 | 6.0 | 5.8 | 5.9 | 5.9 | 6.2 | 6.1 | 6.3 |
| Shares outstanding (diluted) | 8.1 | 6.0 | 5.8 | 5.9 | 5.9 | 6.2 | 6.2 | 6.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |